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ABSTRACT
Treatment of Nightmares Using Imagery Rehearsal Therapy: A Multiple Baseline Study
Michael R. Nadorff
Nightmares have been linked with several negative consequences, including death by
suicide. Further, nightmare sufferers report that nightmares have a significant negative impact
on their lives. To address this problem, several nightmare treatments have been studied, with
Imagery Rehearsal Therapy (IRT) having the greatest amount of empirical support. However,
there are many unanswered questions in regard to IRT, such as how quickly one may see an
effect and whether or not there is a temporary increase in nightmares prior to a decrease. The
current study aimed to address these questions by examining IRT using a non-concurrent
multiple baseline design. Four participants took part in the study, with each receiving IRT over
the course of one session. IRT did not lead to a substantial decrease in nightmare frequency or
severity in this sample, despite strong treatment adherence. The lack of a finding may be due to
there being a great deal of intra-individual variability in frequency of nightmares. . There was
no substantial increase in nightmare frequency, severity, or negative affect in the week following
treatment. However, it is possible that the treatment was ineffective, which could explain why
no temporary increase in nightmares or negative affect was observed. Implications and future
directions are discussed.
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Nightmares are linked to several negative outcomes, including suicide attempts and death
by suicide (Sjöström, Hetta, & Wærn, 2009; Tanskanen et al., 2001). Further, nightmares are
associated with psychological disorders such as post-traumatic stress disorder (Harvey, Jones, &
Schmidt, 2003), anxiety symptoms (Levin & Nielsen, 2007), depressive symptoms (Besiroglu,
Agargun, & Inci, 2005), schizophrenia (Hartmann1981), dissociative disorders (Agargun, Kara,
Ozer, Selvi, Kiran, & Ozer, 2003), and borderline personality disorder (Hartmann, 1981).
Research has provided evidence that nightmares even increase the risk of developing PTSD
(Mellman, David, Kulick-Bell, & Hebding, 1995), and engaging in future suicide attempts in a
sample of suicide attempters (Sjöström, et al., 2009). Despite these associations, research
examining nightmare treatments is still in its infancy. The current study investigated Imagery
Rehearsal Therapy (IRT), a particularly promising nightmare treatment. The current paper will
first present the definition of nightmares and diagnostic criteria for nightmare disorder. Then,
the paper will examine the prevalence of nightmares, as well as their associations with
psychopathology. Lastly, there will be a review of the research on nightmare treatments,
followed by the current investigation of IRT for nightmares.
Nightmare Definition
Nightmares, defined as vivid, disturbing, or frightening dreams that awaken the
individual, are a common form of parasomnia (Levin & Nielsen, 2007). Nightmares primarily
occur during REM sleep, and hence are more common during the second half of the night
(American Academy of Sleep Medicine, 2006). The fact that nightmares occur in REM sleep
differentiates them from night terrors, a parasomnia that occurs in non-REM sleep. Following a
nightmare, an individual is usually fully alert and may have difficulty returning to sleep.
Although there are several sets of criteria for nightmare disorder (discussed later), most require

Treatment of Nightmares Using IRT

2

an individual to have recurrent nightmares that awaken the individual to a state of alertness
(American Academy of Sleep Medicine, 2001, 2006; American Psychiatric Association, 2000).
Disturbing dreams, which are negative dreams that do not lead to a startled awakening,
are usually excluded from the definition of nightmares due to their lack of a startled awakening.
However, disturbing dreams and nightmares are quite similar, as both require awakening from a
negative dream. Although an awakening is not required by the definition of disturbing dreams, it
is implicit as one must awaken to remember a dream. Thus, the only difference between
nightmares and disturbing dreams is whether or not the awakening from the dream was startled.
Due to their similarities, the majority of nightmare studies, including the current study, combine
disturbing dreams and nightmares (Levin & Nielsen, 2007).
Diagnostic Criteria
Currently, there is no single agreed upon set of criteria for diagnosing nightmare disorder.
Therefore, three of the most-used criteria for nightmare disorder are presented here. Although
they have significant differences, all three require (or imply) that a nightmare must suddenly
awaken the individual.
The Diagnostic and Statistical Manual of Mental Disorders, 4th edition text revision
(American Psychiatric Association, 2000) requires the following for the diagnosis of a nightmare
disorder:
A. Repeated awakenings from the major sleep period or naps with detailed recall
of extended and extremely frightening dreams, usually involving threats to
survival, security, or self-esteem. The awakenings generally occur during the
second half of the sleep period.
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B. On awakening from the frightening dreams, the person rapidly becomes
oriented and alert (in contrast to the confusion and disorientation seen in Sleep
Terror Disorder and some forms of epilepsy).
C. The dream experience, or the sleep disturbance resulting from the awakening,
causes clinically significant distress or impairment in social, occupational, or
other important areas of functioning
D. The nightmares do not occur exclusively during the course of another mental
disorder (e.g., delirium, Post-traumatic Stress Disorder) and are not due to the
direct physiological effects of a substance (e.g. a drug of abuse or medication) or
a general medical condition (pg. 634)
The DSM criteria are quite restrictive, as an individual must not qualify for posttraumatic stress disorder or sleep terror disorder in order to meet criteria for a nightmare disorder
diagnosis. Therefore, a large number of individuals with clinically-significant nightmares will
not meet DSM criteria for nightmare disorder.
The International Classification of Diseases (ICD-10) has the simplest criteria of the
three. It defines nightmare disorder as follows:
Dream experiences loaded with anxiety or fear. There is very detailed
recall of the dream content. The dream experience is very vivid and usually
includes themes involving threats to survival, security, or self-esteem. Quite often
there is a recurrence of the same or similar frightening nightmare themes. During
a typical episode there is a degree of autonomic discharge but no appreciable
vocalization or body motility. Upon awakening the individual rapidly becomes
alert and oriented (World Health Organization, 2007).
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Unlike the DSM, the ICD-10 does not exclude individuals with a diagnosis of posttraumatic stress disorder or night terror disorder from receiving a nightmare disorder diagnosis.
The International Classification of Sleep Disorders – Second Edition (ICSD-2;
American Academy of Sleep Medicine, 2006) criteria differ from the DSM criteria in that
an individual may have post-traumatic stress disorder or night terrors and still meet
criteria for nightmare disorder. The ICSD’s criteria for nightmare disorder are as
follows:
A. Recurrent Episodes of awakenings from sleep with recall of intensely
disturbing dream mentation, usually involving fear or anxiety, but also anger,
sadness, disgust, or other dysphoric emotions.
B. Full alertness on awakening, with little confusion or disorientation; recall of
sleep mentation is immediate and clear
C. At least one of the following associated features is present:
1. Delayed return to sleep after the episode
2. Occurrence of episodes in the latter half of the habitual sleep period (p.
156)
Like the ICD-10, the ICSD-2 does not preclude individuals with post-traumatic
stress disorder from receiving a diagnosis of nightmare disorder.
Nightmare Frequency
Nightmares are often thought of as a disorder of childhood (Levin & Nielsen, 2007). It is
estimated that 10 – 50% of children age three to six experience occasional nightmares (American
Psychiatric Association, 2000), with approximately 19% of children experiencing nightmares at
least once per week (Schredl, Biemelt, Roos, Dunkel, & Harris, 2008). Although nightmares
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are often viewed as a childhood sleep disorder, research suggests that nightmares may persist
into adulthood, and are a function of age and sex. In a sample of college students, 53% of
participants reported having nightmares at least once a month and 14% reported nightmares at
least once per week (Nadorff, Nazem, & Fiske, 2011).
In a large study of nightmare frequency, Nielsen, Stenstrom, and Levin (2006) collected
nightmare information from 23,990 individuals using an online questionnaire and found that
women reported significantly more nightmares than men (4.44 per month vs. 3.39). For women,
nightmare frequency increased from ages 10 - 19 to 20 - 39 and then decreased. However, for
men, nightmare frequency remained stable from ages 10-19 through 30-39, and then decreased
after that. Thus, research suggests that the prevalence of nightmares is partially dependent upon
age and sex (Nielsen, et al., 2006).
Studies examining nightmares in adults have found nightmare disorder prevalence rates
ranging from 2% - 6%. This prevalence range is highly consistent across cultures, with similar
rates having been found in the United States, Canada, France, Iceland, Sweden, Belgium,
Finland, Austria, Japan, and the Middle East (Levin & Nielsen, 2007). Very little research has
examined the prevalence of nightmares among older adults. However, the research that has been
done suggests that nightmares may be less common among older adults compared with children
and younger adults. In a study comparing older adults and college students, only 4.3% of older
adults reported having a problem with nightmares, which was significantly less than the 19.5%
of college students in the study reporting having a nightmare problem (Salvio, Wood, Schwartz,
& Eichling, 1992).
Nightmare Theories
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It is often helpful to have a theoretical framework in order to understand a disorder and
its effects. However, nightmares have historically received little attention from theorists or
researchers. Even Freud, who did a considerable amount of work on dreams, rarely discussed
nightmares. In his book The Interpretation of Dreams, Freud only mentions nightmares twice,
and neither time did he provide a theory as to why individuals have nightmares (Freud, 2004).
Contemporary theorists have put forth ideas about the etiology of nightmares, although little
evidence supporting the theories exists. Despite this fact, a review of the current theories is still
warranted, especially given that some of the nightmare treatments are based upon these theories.
After studying the histories of many nightmare sufferers from the psychoanalytic
perspective, Hartmann (2001) concluded that nightmares are caused by “thin boundaries.” Thin
boundaries refer to “the lack of separation between areas and processes in the mind, and also a
lack of walls and defense” (Hartmann, 2001). Hartmann (2001) came to this conclusion based
on the notion that trauma more strongly affects individuals with thin boundaries, and since
nightmares are a manifestation of trauma, thin boundaries must be associated with nightmares.
Supporting this theory, Hartmann (1989) found that thin boundaries (as defined by the Hartmann
Boundaries Questionnaire) were positively correlated with remembering one’s dreams, which
may lead to remembering one’s nightmares. Similarly, other researchers have also found that
thin boundaries are associated with dream recall, more negative and emotionally intense dreams,
and regarding one's dreams to be meaningful (Schredl, Schafer, Hofmann, & Jacob, 1999).
Cartwright (2001) articulated a different view of nightmares, focusing on emotion
processing instead of boundaries. She stated that when a traumatic event occurs, an individual
may be unable to handle all of the resulting emotions at that time. Therefore, nightmares may
emerge in order to help process the emotions caused by the trauma. For most individuals, the
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nightmares will subside once the processing has completed, but for others, the nightmares can
become a chronic problem. Although other theorists agree that emotion regulation may help
explain nightmares (Levin & Nielsen, 2009), to date no research has been published linking
emotion regulation problems with nightmares.
Taking a more biological approach, Levin and Nielsen (2007) published the
AMPHAC/AND Neurocognitive model of disturbed dreaming. The model seeks to explain
disturbed dreaming at both physiological and cognitive levels. The neurophysiological
component of the model, called the AMPHAC network, specifies the involvement of the
following brain structures: "the amygdala (A), the medial prefrontal cortex (MP), the
hippocampus (H), and the anterior cingulate cortex (AC)" (Levin & Nielsen, 2007, p. 84). The
cognitive component of the model is called affect network dysfunction (AND) and is comprised
of affect load (AL) and affect distress (AD). Affect load is defined as the amount of stressful or
negative emotional events a person is experiencing, and affect distress is an individual's
predisposition to react strongly to emotional stimuli. The model posits that the physiological and
cognitive levels serve the function of fear-memory extinction during normal dreaming. In this
process, components of fearful events are combined in a new way with non-fearful memories,
disarming the memories. However, for individuals with significant distress (especially those
who are predisposed to be sensitive to distress), the fearful memories may not be altered, or may
be altered in a way even more frightening than the original memory, leading to disturbing dreams
(Levin & Nielsen, 2009). To date, there is no evidence directly supporting the AMPHAC/AND
Neurocognitive model of disturbed dreaming. However, the lack of evidence may be due to the
recent publication of the model. Furthermore, the AMPHAC/AND model is most consistent
with the activation-synthesis hypothesis of dreaming (Hobson & McCarley, 1977) which is one
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of the most widely-accepted theories of normal dreaming. The activation synthesis hypothesis
postulates that dreaming is an event that is physiologically shaped by the sections of the brain
that are activated during sleep. In an attempt to make sense of the activation, the brain
synthesizes the impulses into a narrative, which we experience as dreams.
Nightmares have also been viewed through a cognitive-behavioral lens. The cognitivebehavioral theory of nightmares posits that nightmares cause sleep avoidance behaviors
(Krakow, Hollifield, et al., 2001; St-Onge, Mercier, & De Koninck, 2009). In this theory, the
nightmare is considered to be a conditioned stimulus that causes a conditioned avoidance
response. The awakening then reinforces the belief that the only way to avoid nightmares is to
remain awake, which leads to the nightmare sufferer developing other behaviors to avoid sleep.
However, there are several limitations to the cognitive-behavioral theory of nightmares. First,
although it explains why nightmare sufferers may sleep less and have poor sleep quality, it does
not provide an explanation for why people have nightmares. Second, the theory is not fully
consistent with behavioral theory.
It stands to reason that individuals become aware of their nightmares due to awakenings,
which are a learned behavior that has been negatively reinforced by waking up during
nightmares, and thereby avoiding the negative content. Put simply, an individual may wake up
and thereby escape from having the nightmare, which negatively reinforces the awakenings that
are serving as an avoidance response. However, the avoidance of the nightmare increases sleep
fragmentation, making an individual more likely to remember their dreams, perpetuating the
nightmare problem. Additionally, it is possible that avoiding the nightmare may prevent
exposure to the nightmare, potentially explaining why nightmares persist.

8
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To date, all of the non-pharmacological treatments for nightmares are based on the
cognitive-behavioral theory of nightmares. Studies have shown significant reductions in
nightmares through use of systematic desensitization (Cellucci & Lawrence, 1978), exposure
(Burgess, Gill, & Marks, 1998), and imagery rehearsal therapy (Krakow, Hollifield et al. 2001),
as discussed below.
Psychological Disorders
In addition to understanding the theories of nightmares, it is important to also know the
relation between nightmares and related disorders, as these relations may affect the development
and treatment of nightmares. Additionally, nightmares may be a precursor to psychopathology
(Mellman, et al., 1995; Ohayon & Shapiro, 2000), and as such nightmares have great clinical
relevance.
Although the most well-known comorbidity is post-traumatic stress disorder, nightmares
are also related to several other psychological disorders. The next section will review the
literature examining disorders that are often comorbid with nightmares.
Post-traumatic stress disorder
Nightmares have a strong association with post-traumatic stress disorder (Harvey, et al.,
2003). The nightmares observed in PTSD (sometimes referred to as traumatic nightmares) are
often re-enactments of the traumatic event, and are consistent with both the re-experiencing and
hyperarousal criteria of PTSD (American Psychiatric Association, 2000). In addition to being
common in PTSD, nightmares are a chronic symptom of PTSD. Two studies examining war
veterans found that nightmares persisted up to 50 years following the traumatic experience
(Guerrero & Crocq, 1994; Kaup, Ruskin, & Nyman, 1994).
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Nightmares are not only related to PTSD, but they may influence the development of
PTSD. PTSD symptoms are more severe among individuals who reported having nightmares
prior to the traumatic event than among individuals who did not report experience nightmares
prior to the trauma (Mellman, et al., 1995). Similarly, Ohayon and Shapiro (2000) found that
insomnia (60.9%) and nightmares (40%) preceded trauma, and the subsequent development of
PTSD, among a large proportion of the sample. These finding suggest that nightmares and
insomnia may be risk-factors for developing PTSD later in life. They also suggest that there may
be a certain vulnerability that both sleep difficulties and PTSD share.
For individuals who have been diagnosed with PTSD, nightmares have been shown to be
associated with poorer outcomes. Mellman and colleagues (2001) followed 60 individuals who
experienced a life-threatening trauma. They found having nightmares of the trauma shortly after
the trauma were related to more severe PTSD symptoms six weeks later. Conversely,
individuals with PTSD rate their nightmares as being more distressing than nightmare sufferers
without PTSD (Germain & Nielsen, 2003).
In sum, nightmares and PTSD are closely related. The fact that nightmare and PTSD
onset and severity have a reciprocal relation leads one to wonder if there is a common
vulnerability that underlies both disorders. As such, it is possible that treating one disorder may
help the other.
Anxiety Symptoms
Nightmares are also related to anxiety symptoms in children, adolescents, adults, and
psychiatric inpatients (Levin & Nielsen, 2007). In particular, nightmares are related to death
anxiety, fear of annihilation, and neuroticism (Levin & Nielsen, 2007). Although few studies
have separated nightmare frequency from severity, the studies that have suggest that the relation
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between nightmares and anxiety symptoms may be driven by nightmare severity, not frequency.
Levin and Fireman (2002) found that nightmare severity correlated much more strongly with
symptoms of depression and anxiety than with nightmare frequency.
Although research has demonstrated an association between nightmares and anxiety
symptoms, much is not known. To date, research has not examined if nightmares precede or
follow anxiety symptoms. Knowing the precedence of disorders may help in understanding the
etiology of both nightmares and anxiety disorders. This is important for nightmare treatment as
the efficacy of nightmare treatments may differ depending upon whether nightmares are the
primary problem, or result from the anxiety. For example, if nightmares are due to high levels of
anxiety, and the anxiety remains untreated, nightmares may not be reduced by nightmare
treatments due to the core problem being anxiety.
Depressive Symptoms
Although sparse, research has demonstrated a link between nightmares and depressive
symptoms. The majority of the research investigating nightmares and depression has focused on
the relation between nightmares and melancholic features within depression. Besiroglu,
Agargun, and Inci (2005) found that nightmares were significantly more common among
depressed individuals with melancholic features than among those without melancholic features.
Further, depressed suicide attempters with melancholic features have been shown to have more
nightmares than suicide attempters without melancholic features (Agargun et al., 2007).
Very little research has examined whether having nightmares increases the likelihood of
having depression. Utilizing a multiple regression analysis, Levin and Fireman (2002) found
that nightmare distress was significantly related to higher levels of depressive symptoms.
Nightmare frequency was not significantly related to depressive symptoms after statistically
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controlling for nightmare distress. Similar to anxiety, further research is needed to explore the
precedence of nightmares and depression, as the precedence may influence treatment outcomes.
Schizophrenia
In line with Hartmann’s thin boundaries theory, research has demonstrated a link between
nightmares and schizophrenia-spectrum disorders. Hartmann (1981) examined 38 adults who
reported having at least one nightmare per week. Four met DSM-III criteria for schizophrenia
(11%) and six met criteria for schizotypal personality disorder (16%). These rates are higher
than the rate of schizophrenia (0.5% - 1.5%) and schizotypal personality disorder (3%) found in
the general population (American Psychiatric Association, 2000). However, it should be noted
that while not an inpatient sample, nearly 75% of Hartmann’s sample had received psychiatric
services in the past, and 10% had a prior inpatient hospital stay. Further, Herz and Melville
(1980) found that nightmares are a common precursor of relapse of schizophrenia.
Nightmare sufferers also have elevated scores on measures validated to detect
schizophrenia. Hartmann and colleagues (1987) found that nightmare sufferers scored
significantly higher on the Minnesota Multiphasic Personality Inventory subscales associated
with psychosis. Similarly, Levin (1998) demonstrated that nightmare sufferers had greater levels
of schizotypy than individuals in the control group.
Although the mechanism is not clear, a strong link exists between nightmares and
schizophrenia. Although untested, the relation between nightmares and schizophrenia may help
explain why some researchers have found that individuals with PTSD are more likely to have
comorbid schizophrenia (Davidson, Hughes, Blazer, & George, 1991).
Dissociative Disorders
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Dissociative disorders have been linked to acute stress disorder and post-traumatic stress
disorder (Agargun, Kara, Ozer, Selvi, Kiran, & Kiran, 2003), suggesting they may be associated
with nightmares as well. A few studies support a link between dissociative disorders and
nightmares. Agarun and colleagues (2003) found that 57% of individuals with a dissociative
disorder met criteria for a nightmare disorder. This rate is much higher than the 2 – 7%
prevalence of nightmare disorder found in community samples (Levin & Nielsen, 2007).
Individuals who report nightmares also have more dissociative symptoms than do individuals
without nightmares. In a sample of 292 undergraduate students (age 16 - 21), those who reported
having nightmares scored significantly higher on the Dissociative Experiences Scale than those
who did not report having nightmares (Agargun, Kara, Ozer, Selvi, Kiran, & Kiran, 2003).
Similarly, Semiz, Basoglu, Ebrinc, and Cetin (2008) found a significant correlation (0.43)
between the Dissociative Experiences Scale and nightmare frequency among individuals with
borderline personality disorder.
To date, it is not clear why nightmare sufferers are more likely to experience dissociative
symptoms, nor is it clear if this relation holds for nightmare sufferers who have not experienced
a traumatic event. Theoretically, it makes sense that dissociative disorders and nightmares are
related because both are believed to be associated with having thin boundaries (Hartmann, 1989).
If this is a common thread, an intervention that strengthens boundaries may be beneficial for both
nightmares and dissociative symptoms in those who suffer from both.
Borderline Personality Disorder
Researchers have also found a link between nightmares and borderline personality
disorder. In Hartmann’s (1981) sample of 38 adults with weekly nightmares, he found that nine
of the participants (24%) met DSM-III criteria for borderline personality disorder. This rate is
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higher than the rate of borderline personality disorder (2%) found in the general population
(American Psychiatric Association, 2000). Similarly, Claridge, Davis, Bellhouse, and Kaptein
(1998) found that nightmare distress correlated strongly (0.42) with the borderline personality
scale in a sample of 60 undergraduate women.
Individuals with borderline personality disorder have also been shown to report more
nightmares than those without borderline personality disorder. Semiz, Basoglu, Ebrinc, and
Cetin (2008) compared a sample of 88 participants diagnosed with borderline personality
disorder with age and sex-matched controls. The patients with borderline personality disorder
reported more nightmares, greater dream anxiety, and more disturbed sleep than the control
participants. Further, those with borderline personality disorder and a nightmare disorder
exhibited more severe psychopathology than those with borderline personality disorder but
without a nightmare disorder.
The relation between nightmares and borderline personality disorder is interesting, as it
may help explain the findings that nightmares are associated with suicidal behavior (Cukrowicz
et al., 2006; Nadorff, et al., 2011; Sjöström, et al., 2009; Sjöström, Wærn, & Hetta, 2007;
Tanskanen, et al., 2001). Borderline personality disorder has been associated with several
negative outcomes, including suicidal behavior. Suicidal behavior is common in the disorder,
with approximately 10% of those diagnosed with borderline personality disorder dying by
suicide (Paris, 2002), and suicidal behavior is one of the DSM-IV criteria for the disorder
(American Psychiatric Association, 2000). To date, no study has examined whether or not the
relation between nightmares and suicide is mediated by borderline personality disorder.
Suicide
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A substantial and growing literature suggests that nightmares increase one’s risk of
suicidal behavior. Cukrowicz and colleagues (2006) found that disturbing dreams or nightmares
were significantly related to suicidal ideation in a college sample (Mean age = 19.2 years).
Multiple regression revealed that nightmares were associated with suicidal ideation independent
of insomnia symptoms. Similarly, we (Nadorff, et al., 2011) examined the relation between
nightmares and suicidal ideation in a sample of 583 college students (Mean age = 19.4 years).
We found that nightmares were associated with suicidal ideation after statistically controlling for
the symptoms of depression, anxiety, and post-traumatic stress disorder, B = 0.021, SE = .008, p
= .01.
Nightmares have also been examined in relation to suicide attempts. Sjostrom, Waern,
and Hetta (2007) studied 165 patients age 18 to 68 years (M = 35.3 years) who had been
admitted to the hospital following a medically serious suicide attempt. Although insomnia was
the most common sleep complaint, two-thirds of participants also reported having nightmares. A
regression analysis revealed that onset insomnia, terminal insomnia, and nightmares were all
significantly associated with higher scores of suicidality, defined as the risk of attempting
suicide. Nightmares remained significantly related to high suicidality after controlling for DSM
axis I disorders, posttraumatic stress disorder diagnoses, depression symptoms, and anxiety
symptoms, adjusted OR = 3.50, 95% CI = 1.57 - 7.81, p < .01. Further, a follow-up study found
that persistent nightmares predicted suicide attempts in the next two years in the same sample
after controlling for DSM Axis I disorders, adjusted OR = 4.18, 95% CI = 1.47 - 11.89, p < .01
(Sjöström, et al., 2009).
Nightmares are also related to death by suicide. Tanskanen et al. (2001) examined the
relation between nightmares and death by suicide in a prospective study conducted in Finland.
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When compared with individuals without nightmares, those reporting occasional nightmares
were at 57% greater risk of death by suicide. Further, participants reporting frequent nightmares
were at 107% greater risk of suicide compared to those without nightmares. This study suggests
that nightmares are potentially a risk factor for suicide.
Although nightmares are associated with several disorders, temporal precedence has not
been investigated. Therefore, it is unknown whether nightmares cause other disorders, or
whether the nightmares are a product of the other disorders. This is important, because the
presence of co-morbid disorders may affect the efficacy of nightmare treatment. Further, few
studies have examined nightmare disorder diagnosis, instead utilizing nightmare frequency or
severity ratings.
Research on Nightmare Treatment
Four main types of psychosocial interventions have been used in the literature to treat
nightmares: exposure, systematic desensitization, lucid dreaming, and imagery rehearsal therapy.
This section will summarize the research that has been conducted on each of these four
interventions to examine their efficacy as well as their strengths and limitations.
Systematic Desensitization
Systematic desensitization, a gradual exposure method where an individual utilizes
relaxation techniques while being exposed to a hierarchy of fears, was one of the first treatments
used to treat nightmares (Cellucci & Lawrence, 1978; Miller & DiPilato, 1983). Cellucci and
Lawrence (1978) recruited a sample of undergraduate students who retrospectively reported
having at least two nightmares per week. These undergraduates were asked to track their
dreams, and those who reported having at least one nightmare per week were enrolled in the
study (N = 29). The participants were asked to log when they had a nightmare and the distress it
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caused (10-point scale) over the course of 8 weeks. Then the participants were randomly
assigned to either five sessions of systematic desensitization, placebo (a nightmare discussion
group), or continuous tracking of nightmares. The treatment consisted of five sessions.
Systematic desensitization and the placebo group both resulted in a significant reduction in
nightmare frequency. However, the systematic desensitization group improved significantly
more than the placebo group in nightmare frequency and severity.
Miller and DiPilato (1983) investigated using systematic desensitization to treat 32 selfreferred nightmare sufferers. The sample was mostly female and averaged having nine
nightmares per month. The authors stated that individuals with major psychopathology were
excluded, but did not state what constituted major psychopathology. The participants were
randomly assigned to six weekly sessions of relaxation training, systematic desensitization, or a
waitlist control. Immediately following treatment, there was a significant reduction in nightmare
frequency, but not intensity, for both systematic desensitization and relaxation training when
compared with the waitlist control group. However, 25 weeks post-treatment, nightmare
intensity was also found to be significantly reduced in the systematic desensitization group.
These two studies support of the use of systematic desensitization for nightmares.
However, there are a few limitations: systematic desensitization requires several additional
sessions (5-6 sessions vs. 1 for IRT), and it may be perceived as more aversive than IRT or lucid
dreaming to the client due to the client being exposed to more of the negative content of the
nightmare when compared to IRT or lucid dreaming. Nonetheless, systematic desensitization
appears to be promising, despite these limitations.
Exposure
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Treating nightmares through exposure involves confronting an individual with his or her
nightmare until it is no longer causing the individual significant distress. To date, only two
studies have evaluated the efficacy of treating nightmares using exposure therapy (Burgess, et
al., 1998; Grandi, Fabbri, Panattoni, Gonnella, & Marks, 2006). However, both of these studies
have found that exposure treatment results in significant reductions in nightmares.
Burgess and colleagues (1998) investigated the efficacy of using a self-administered
exposure treatment. They recruited 107 nightmare sufferers through media advertisements.
Potential participants were then mailed questionnaires to assess if they met DSM-III-R criteria
for recurrent nightmares. In order to be included in the study, participants had to be at least 18
years of age, have nightmares for at least one year, have the nightmares occur at least weekly
over the last 6 months, and have scores greater than 5 out of 11 on distress and sleep disturbance
caused by the nightmares. The exclusion criteria were severe psychiatric illness, night terrors,
narcolepsy, sleep paralysis, asthma, taking a medication that is likely to cause nightmares, and
drinking more than two (three for men) alcoholic drinks per day. The participants meeting these
criteria were randomized into either a self-exposure, self-relaxation, or wait-list control group.
Similar to the previous study, participants spent between 30 and 60 minutes daily for a period of
four weeks doing the self-exposure treatment. Participants in the self-exposure group had a
significantly greater reduction in nightmares (d = 1.18) at one and six months post-treatment
when compared with the self-relaxation and wait-list groups. Additionally, those who received
the self-exposure treatment also experienced a significant reduction in their depressive symptoms
(d = .76).
Grandi and colleagues (2006) also investigated the efficacy of a self-exposure treatment
for nightmares. They recruited a sample of 10 nightmare sufferers who met DSM criteria for
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nightmare disorder. Since the DSM criteria were used, all DSM axis I and II disorders other than
nightmares and medications that potentially cause nightmares were exclusion criteria. The
authors had the participants track their nightmares over three months and then taught the
participants how to do self-directed exposure in the morning following having a nightmare. The
participants were asked to work for 30-60 minutes in a workbook for a period of four weeks and
then participated in follow ups immediately post-treatment as well as 3, 4, 5, 7, 10, 16, 28, and
52 months post-treatment. The authors found that the exposure treatment significantly reduced
not only nightmare frequency and intensity, but also symptoms of anxiety, depression, and
sleeplessness at the post-treatment follow-up. Remarkably, most of the gains were maintained
over four years.
Both studies that examined use of self-administered exposure found strong positive
results. However, both relied on participants doing a significant amount of homework each day
(30-60 minutes), which may affect compliance and may even be impossible for some nightmare
sufferers. Also, similar to systematic desensitization, exposure requires the client to reexperience the entire nightmare, instead of only part of the nightmare as in IRT, and hence may
be more aversive than IRT or lucid dreaming. Overall, self-exposure therapy appears to be a
promising treatment, although it is limited due to requiring a significant amount of homework
and the possibility that it may be aversive.
Lucid Dreaming Therapy
The lucid dreaming approach to nightmares differs significantly from exposure and
systematic desensitization. Instead of exposing an individual to his/her nightmare in order to
reduce nightmare severity, lucid dreaming therapy involves helping individuals realize when
they are dreaming and, once this realization is made, helping them learn how to change their
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dream while they are having it. In lucid dreaming therapy, participants are trained to be able to
identify and change their dream while they are dreaming. Some strategies used to train lucid
dreaming are testing reality and identifying “dreamsigns” which are events that do not occur in
real life (The Lucidity Institute, 1993). Once able to identify when they are dreaming, the
participants are instructed to actively change their dream, while experiencing it, so the ending is
positive. Thus, positive ending is not designed beforehand, nor is it rehearsed, as is done in IRT,
but rather the participant determines the ending while asleep (Spoormaker & van den Bout,
2006).
Lucid dream frequency has been shown to be related to nightmare frequency, and it has
been hypothesized that nightmares may trigger lucid dreaming (Schredl & Erlacher, 2004).
Given that individuals with nightmares may be more likely to have lucid dreams (Schredl &
Erlacher, 2004), and those who do not already have lucid dreams can be taught (Purcell,
Mullington, Moffitt, & Hoffmann, 1986), it makes sense to try to train nightmare sufferers to
become lucid and change their nightmare while the nightmare is occurring.
To date, there have only been two studies investigating the efficacy of lucid dreaming
therapy on nightmares (Spoormaker & van den Bout, 2006). In the first study, 23 nightmare
sufferers were randomly assigned to either a two-hour individual lucid dreaming treatment
session, a two-hour group lucid dreaming treatment session, or a waitlist control group.
Homework was utilized following treatment, although the type, frequency, and duration of the
homework were not mentioned. At post-test (12 weeks after treatment), participants receiving
both the individual and group treatment reported significantly fewer nightmares when compared
to pre-treatment baseline. However, there was no significant difference between the treatment
and control groups, and no significant change in sleep quality or PTSD symptom severity. In the
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second study, Lancee and colleagues (2010) compared IRT, IRT and sleep hygiene, IRT and
lucid dreaming, and waitlist control. Surprisingly, IRT alone was shown to be more effective
than the other two treatment conditions, and was the only treatment condition that resulted in a
significant improvement in nightmares compared to the control group. However, the authors
state that the lack of significant results for the other conditions may have been due to low power
and high rates of attrition.
The lucid dreaming approach differs significantly from the other nightmare treatments.
Instead of trying to reduce the frequency or severity of nightmares, it attempts to stop nightmares
mid-way through. A strength of lucid dreaming is it more pleasant to the client than exposure or
systematic desensitization, although some aspects of exposure are present, as one has to imagine
their dream as part of the treatment. Nonetheless, the research findings thus far are weak, with
individuals receiving the lucid dreaming treatment failing to out-perform the wait-list control
group. Thus, based on the current literature, lucid dreaming is not a good option for treating
nightmares.
Imagery Rehearsal Therapy
Imagery rehearsal therapy (IRT) is by far the most widely researched of the nightmare
treatments with eleven articles having been published on its efficacy. It may also be one of the
most pleasant treatments, as the client is not repeatedly exposed to their full nightmare. In
imagery rehearsal therapy, the client is instructed to imagine their nightmare but change the
ending in any way they want. Once they have done this, they are encouraged to rehearse the new
dream at least once a day for at least a week. Over time, it is expected that the nightmare will
change from the old nightmare into a new dream.
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Imagery rehearsal therapy is based on the theory that nightmares are “a learned behavior”
(Krakow, 2002, pg 18) and, as such, can be replaced by a more pleasant behavior (in this case a
new dream) that achieves the same function. The client practices a new dream through imagery
exercises, and over time, a new dream replaces the old nightmare. Another possible explanation
for IRT’s effectiveness can be found in the activation-synthesis model (Hobson & McCarley,
1977), which posits that dreams are the byproduct of events based on waking experiences. By
imagining the new dream daily, the new dream content may be incorporated into one’s dreams
due to it being part of one’s daily experience.
The first investigation of imagery rehearsal therapy consisted of 20 individuals who were
randomly assigned to treatment or to nightmare recording (Neidhardt, Krakow, Kellner, &
Pathak, 1992). Imagery rehearsal therapy was administered in one session, with participants
being instructed to practice the imagery once a day for at least three days for each nightmare that
they desired to change. The authors followed up with all participants three months after
treatment. The authors found that nightmare frequency significantly decreased in both groups,
but there was no significant difference between the imagery rehearsal therapy and recording
groups (d = 1.28 for IRT, 0.67 for recording). However, given that the effect size for the
recording group was fairly large, one has to wonder whether the study was adequately powered.
Symptoms of depression (d = 0.82) and anxiety (d = 0.62) were both significantly reduced in the
imagery rehearsal therapy group. After 30 weeks, both the IRT and recording group (which
received IRT three months after the IRT group) demonstrated significant decreases in nightmare
frequency (the authors did not state if these groups significantly differed). However, only the
imagery rehearsal therapy group had a significant decrease in nightmare severity after 30 weeks
(Krakow, Kellner, Neidhardt, Pathak, & Lambert, 1993).
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Building upon the promising results of the first study, Krakow and colleagues (1996)
examined IRT utilizing a sample of 58 chronic nightmare sufferers who had nightmares at least
once per week. In this uncontrolled trial participants received a single, 2.5 hour group IRT
session. The participants were instructed to practice the imagery of their new dream at least once
a day following treatment. The researchers then followed up with the participants after three and
18 months. The authors found a significant decrease in nightmare frequency from baseline to
three and 18 month follow-up. They also found that there was a significant decrease in
nightmare frequency from three months following treatment to 18 months suggesting that the
patients continued to improve more than three months after treatment. In addition to decreases in
nightmare frequency, anxiety symptoms were significantly reduced (d = 0.4). However,
depressive symptoms were not significantly reduced between pre-treatment and 18-month
follow-up (d = 0.18).
In the first study to investigate imagery rehearsal therapy in a sample with PTSD,
Krakow and colleagues (2000) conducted a large randomized controlled trial utilizing 169
female survivors of sexual assault with PTSD. The 87 participants receiving the treatment
received three group sessions of imagery rehearsal therapy over a period of five weeks. After
three months, nightmares frequency was significantly reduced in the treatment group when
compared with the wait-list control group (d = 1.2). In addition to nightmare frequency being
reduced, PTSD symptoms were also significantly reduced (d = 1.2) in the group that received
treatment. This finding suggests that imagery rehearsal therapy may be an effective treatment
for PTSD symptoms in those with PTSD and nightmares.
Krakow and colleagues (2001a) attempted to replicate the previous study with another
large randomized controlled trial of imagery rehearsal therapy in women with PTSD. In this
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study of 168 female participants with PTSD, 88 were randomized into the treatment condition
and 80 into the waitlist control. In addition to nightmare frequency, the authors assessed sleep
quality and PTSD symptoms. The participants received three sessions of imagery rehearsal
therapy and were instructed to practice the imagery of their new dream for between 5 and 20
minutes per day. Further, participants were instructed to not try to change more than two dreams
per week. The researchers conducted a follow-up with participants after three and six months.
The authors found that the treatment group had significantly reduced nightmares (d = 0.85),
improved sleep quality (d = 0.67), and reduced PTSD symptoms (d = 1.0) relative to the control
group.
Krakow and colleagues (2001b) further extended the IRT findings by testing it in a
sample of adolescent girls who had suffered a sexual assault. The sample consisted of 19
adolescent girls at a treatment facility who were randomly assigned to either the treatment (n = 9)
or control (n = 10) group. The treatment group received IRT in a six hour workshop conducted
over one day. The treatment group was instructed to practice the imagery for 5 to 20 minutes
every day. The control group received no intervention. After three months, the treatment group
reported a 71% decrease in nightmare frequency (d = 1.7) whereas there was no change in the
control group. However, since the control group received no treatment, it is impossible to
determine whether the improvement is due to the placebo effect. However, there was no
significant difference between the groups in PTSD symptoms (d = 0.22 for the treatment group
and 0.27 for the control group).
St. Onge, Mercier, and De Konick (2009) extended IRT research even further by utilizing
the treatment in a sample of 20 children age 9 – 11 with moderate to severe nightmares without
PTSD. The researchers advertised for the study by posting and distributing 18,000 flyers. From
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those fliers the researchers received 109 phone calls from interested participants of which 50
(46%) of the children met criteria. Of these 50, 24 chose not to participate, and six dropped out
during the study, leaving a sample of 20. The inclusion criteria were that the participant was
between 9 and 11 and had one or more nightmare per week for six months or more. Participants
were excluded if they took medications that affect sleep, had trauma-related nightmares, or had
co-morbid affective conditions or PTSD. The children were randomly assigned to IRT (n = 9) or
waitlist control (n = 11). The intervention consisted of an initial meeting, a one-session
treatment with unspecified homework four weeks later, and two follow-up sessions (eight weeks
and nine months). The authors found that nightmare frequency was significantly reduced in the
IRT group when compared with the waitlist control group, and this difference was maintained
over nine months.
Forbes and colleagues (2003) were the first to study IRT in a veteran sample. Their
sample consisted of 12 Australian Vietnam veterans who had been treated for PTSD in the past
but still were having at least one trauma-related nightmare per week. The 12 participants took
part in six weekly 90 minute group sessions and then were assessed at post-treatment, after three
months, and after one year. At post-treatment there were significant reductions in nightmare
frequency (d = 0.70), nightmare intensity (d = 0.55), depression symptoms (d = 0.43), and
anxiety symptoms (d = 0.20). All of the significant treatment gains were still present at the year
follow-up showing that IRT had a lasting impact in this sample. However, due to the absence of
a control group, it is impossible to determine whether IRT was effective beyond placebo effect.
In the only study utilizing polysomnography to investigate IRT, Germain and Nielsen
(2003) examined the impact of one session of imagery rehearsal therapy on nightmare frequency,
psychological distress, and sleep quality (measured by polysomnography) in an uncontrolled
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study. Participants had to be at least 18 years of age and had to report having one nightmare per
week for at least 6 months. IRT was conducted in a small group format over one session. At
follow-up approximately two months post-treatment, participants had significantly fewer
nightmares (d = 1.06) and significantly less anxiety symptoms (d = 1.01) than prior to treatment.
However, reductions in depressive symptoms (d = 0.79) and nightmare distress (d = 0.9) failed to
reach significance. Also, due to the lack of a comparison group, it is unclear whether the
reduction in nightmares was due to IRT or a placebo effect. Polysomnography revealed no
significant difference in the percent of sleep that was REM sleep, REM latency, or REM density
post-treatment.
Nappi and colleagues (2010) extended the work done by Forbes and colleagues (2003)
by testing imagery rehearsal therapy in a larger sample of 58 veterans. Imagery rehearsal
therapy was given over the course of 5 sessions. However, it should be noted that IRT was not
administered in a standardized way and was given in both individual and group format.
Nonetheless, at the end of treatment there was a significant decrease in nightmare frequency (d =
0.45), nightmare severity (d = 0.81), insomnia symptoms (d = 0.72), and PTSD symptoms (d =
1.03). However, since a control group was not utilized, one cannot determine whether IRT was
effective beyond the placebo effect.
In sum, there is a growing literature suggesting that imagery rehearsal therapy is effective
in treating nightmares. Further, several studies suggest that treating nightmares with imagery
rehearsal therapy may also improve sleep quality, and reduce symptoms of insomnia, depression,
anxiety, and PTSD. It has been shown to reduce nightmare frequency (and in some studies,
severity) in children, adolescents, adults, and veterans. Although the literature on IRT is
substantial, much of the supporting studies are uncontrolled. Similar to exposure therapy, IRT
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requires daily practice, which may affect compliance. It is also not clear that IRT is a more
effective treatment than recording one’s nightmares, which may be a form of exposure. It is also
unclear whether the reduction in psychopathology (i.e. symptoms of depression, anxiety, and
PTSD) precedes or succeeds a reduction in nightmares. Thus, research has yet to determine
whether the reduction in nightmares leads to reductions in symptoms of psychopathology, or vice
versa.
Research investigating whether treating nightmares using IRT reduces suicidal behaviors
is needed. Nightmares have been found to be related to suicidal ideation (Nadorff, et al., 2011),
and predict future suicide attempts (Sjöström, et al., 2009) and death by suicide (Tanskanen, et
al., 2001). It is possible that reducing nightmares would also reduce suicidal ideation and make
an individual less likely to attempt or die by suicide in the future. Imagery rehearsal therapy
seems like a logical choice to treat nightmares among individuals who have been hospitalized
due to suicide risk as research has demonstrated that it can be effectively administered in one
session (Krakow, Kellner, Pathak, & Lambert 1996), and hence can be conducted during a short
hospitalization. However, Barry Krakow, the author of the treatment, has suggested that one’s
nightmares may get worse shortly after receiving IRT due to the client focusing on their
nightmares and the distress they cause as a part of treatment, and hence it may not be appropriate
for suicidal individuals (Talbot, 2009). Although there are no data showing that nightmares get
worse after receiving IRT, primarily due to the lack of studies utilizing continuous measures of
nightmares, it would be inappropriate to test IRT on individuals at risk of suicide until it is
known if IRT results in a brief increase in nightmares, and if so, if this increase is related to
higher levels of depressive symptoms and suicidal ideation.
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Statement of the Problem
Nightmares are common, with approximately 2-6% of the adult population likely
suffering from a nightmare disorder (Levin & Nielsen, 2007). This fact is significant not only
because of the distress caused by nightmares, but also because nightmares have been linked with
several other mental health disorders, such as PTSD (American Psychiatric Association, 2000).
Imagery rehearsal therapy has shown promise not only for treatment of nightmares but
also potentially for treating other disorders. Research has demonstrated that IRT significantly
reduces not only nightmare frequency but also symptoms of anxiety, depression, and PTSD
(Krakow, Johnson, et al. 2001). However, few studies have evaluated the effects of conducting
IRT using a single session format. The studies that have been conducted utilizing a one session
treatment failed to measure nightmare severity in addition to nightmare frequency. A study
examining the impact of one session of imagery rehearsal therapy on nightmare severity would
significantly add to the literature and would support the use of imagery rehearsal therapy as a one
session treatment.
A significant limitation of all of the studies examining imagery rehearsal therapy to date
is they have not examined nightmares continuously following treatment. Instead, they followed
up with participants several months later. A study that utilizes continuous measurement of
nightmares would significantly add to the literature by enabling researchers to examine how
quickly imagery rehearsal therapy reduces nightmares.
The literature on imagery rehearsal therapy is also limited by the fact that no study has
examined the temporal precedence of the reduction in nightmares compared with the reduction
of the symptoms of psychopathology. Knowing the temporal precedence would help in
understanding the mechanism by which nightmares occur, which may help in developing
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treatments for nightmares. Lastly, little research has examined the effects of IRT using an
objective measure of sleep. Using a more objective measure to immediately account for a
nightmare as soon as it happens would help reduce error caused by inaccurate memories.
The current study aimed to address these limitations through testing imagery rehearsal
therapy utilizing a non-concurrent multiple baseline design in a sample of adults. The current
study measured nightmare frequency continuously using an immediate report method (actigraphy
event marker) and a daily reporting method (online questionnaire). The study also examined
nightmare severity continuously through an online questionnaire.
The current project assessed nightmares and mood daily, as well as suicidal ideation at
three points, to help determine whether treating nightmares leads to a brief increase in
nightmares, depressed mood, and suicidal ideation. If this is the case, IRT may be contraindicated for individuals at risk of suicide.
Present Study
The present study sought to examine and characterize IRT by utilizing a non-concurrent
multiple baseline design. The study had two primary aims: the first aim was to determine
whether nightmares are reduced through use of imagery rehearsal therapy and the second aim
assessed whether imagery rehearsal therapy results in an increase in nightmares shortly after
treatment. Actigraphy was also used throughout the study to help differentiate between sleep
and wake in the participants.
Aim 1: To determine whether or not nightmares and disturbing dreams (measured together) are
reduced through use of IRT
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Hypothesis 1: There will be a decrease of at least two nightmares and disturbing dreams
per week between baseline and the end of the follow-up period after treatment with
Imagery Rehearsal Therapy.
Hypothesis 2: There will be a decrease in nightmare and disturbing dream severity
between baseline and the end of the follow-up period after treatment with Imagery
Rehearsal Therapy.
Hypothesis 3: Participants will have fewer nocturnal awakenings of 10 minutes or longer
as of the end of the follow-up period when compared to baseline.
Hypothesis 4: Participants will have higher sleep efficiency as of the end of the follow-up
period when compared to baseline.

Aim 2: To determine whether or not IRT results in a temporary increase in nightmares following
treatment.
Hypothesis 5: There will be an increase in nightmare and disturbing dream frequency in
the week following treatment when compared with baseline.
Hypothesis 6: There will be an increase in nightmare and disturbing dream severity in the
week following treatment when compared with baseline.
Hypothesis 7: There will be an increase in negative affect in the week following
treatment when compared with baseline.

The study also had an exploratory aim: to characterize the nightmares experienced by
participants. To characterize the nightmares experienced by participants, the investigator asked
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participants to describe their nightmares in the initial study session and then conducted a directed
content analysis of the descriptions.
Method
Participants
Participants were recruited from the community through online, television, and Personal
Rapid Transit system (PRT) advertisements, as well as newspaper stories. The inclusion criteria
required participants to report, on average, at least three nightmares per week for at least the last
six months and meet the ICSD-2 criteria for nightmare disorder (American Academy of Sleep
Medicine, 2006), to be included in the study. Requiring three nightmares per week, on average,
is higher than the cutoff for other nightmare treatment studies. However, the higher threshold
was selected to attempt to avoid floor effects, and to be consistent with the mean nightmare
frequency at baseline found in other studies. Participants were excluded from the study if they
reported taking any medications that may cause nightmares, reported current suicidal ideation, or
if they reported that they were currently abusing drugs or alcohol. Participants who completed
the study received $300 compensation for their time and effort.
In total, 42 individuals contacted the researchers inquiring about participation in the study
(see Figure 1). Of these, 14 passed the initial screening (assessing whether the individual
reported, on average, three nightmares per week or more) and were invited to come in for a
screening session. Two of these individuals failed to come to the initial appointment, leaving 12
participants. A total of six participants met study criteria and were invited into the study.
However, one participant declined participation due to not wanting to wear the actigraph, and the
other had a disconnected phone and did not respond to emails from the research team, resulting
in four participants who successfully entered and subsequently completed the study. Participant
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001 was a 50 year old caucasian female. She had completed an associate’s degree and was in a
committed relationship. Participant 008 was a 22 year old Hispanic female. She had completed
some college and was in a committed relationship. Participant 010 was a 42 year old caucasian
female. She had completed an advanced degree and was in a committed relationship. Lastly,
Participant 012 was a 23 year old caucasian female. She had completed a bachelor’s degree and
was in a committed relationship.. The study was conducted in accordance with the IRB protocol
and APA ethical guidelines. Informed consent was obtained from all participants.
Measures
Actigraphy. The participants’ sleep and wake periods were objectively estimated for the
duration of the study utilizing an Actiwatch-64 (AW-64) actigraph (Philips-Respironics Mini
Mitter). Actigraphy has been validated against polysomnography, which is considered the gold
standard for measuring sleep (de Souza et al., 2003; Jean-Louis et al., 1996; Sadeh & Acebo,
2002). The actigraph estimates sleep and wake periods by detecting a participant’s movement
over an epoch, or specified time period. The current study utilized 30-second epochs, which
allowed the actigraph to store 22 days of data. The AW-64 is equipped with an event marker
button, which the participants pushed whenever they went to bed, woke up in the morning, or
had a nightmare. The number of nightmares was determined by subtracting two (one for bed
time and one for wake time) from the total number of event marks, with the remainder being
nightmares. Nocturnal awakenings were identified by an Excel macro that identified times when
there were 20 consecutive epochs (for a total of 10 minutes) of wake following sleep. The data
were analyzed using Actiware Software Version 5.4.
Daily Nightmare Ratings. To date there is no validated measure designed to assess
nightmares daily. However, several previous studies investigating nightmare treatments have
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had participants record their nightmare frequency and severity daily (Burgess, et al., 1998;
Cellucci & Lawrence, 1978; Forbes, et al., 2003; Grandi, et al., 2006; Nappi, et al., 2010). The
current study assessed daily nightmare frequency in a similar way. Participants were asked to
press the event marker on the actigraph whenever they had a nightmare. In addition, participants
logged in to a secure website and report how many nightmares they had during the previous
night. Participants rated the severity of their nightmares for the night on a 0 to 4 Likert-style
scale (0 = not distressing - 4 = very distressing).
Beck Anxiety Inventory (BAI; Beck & Steer1993a). The BAI is a 21-item self-report
measure that has been validated to measure anxiety symptoms over the last week. Each item is
scored on a 0 to 3 scale with total scores for the scale ranging from 0 to 63. Scores of 0 - 7
indicate minimal levels of anxiety symptoms, 8 - 15 indicate mild anxiety symptoms, 16 - 25
indicate moderate anxiety symptoms, and 26 or greater indicate severe anxiety symptoms. The
BAI has high internal consistency with an alpha of 0.92 and test-retest reliability of 0.75 (Beck &
Steer1993a). The BAI was collected during the baseline session, treatment session, and final
session.
Beck Depression Inventory-Second Edition (BDI-II; Beck, Steer, & Brown, 1996).
The BDI-II is a 21-item self-report measure that has been validated to measure depressive
symptoms over the last two weeks. It was revised from the original Beck Depression Inventory
(Beck & Steer1987) to be in-line with the DSM-IV. Items are scored on a 0 to 3 scale, with a
total possible score being 63. Scores from 0 - 13 indicate minimal depressive symptoms, 14 - 19
indicate mild depressive symptoms, 20 - 28 indicate moderate depressive symptoms, and scores
of 29 or higher indicate severe depressive symptoms. The BDI has high internal consistency and
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one-week test-retest reliability (Beck, Steer, & Brown 1996). The BDI was collected during the
baseline session, treatment session, and final session.
Beck Hopelessness Scale (BHS; Beck & Steer1993b). The BHS is a 20-item, true-false
measure of hopelessness. It was designed to assess three components of hopelessness: feelings
about the future, loss of motivation, and expectations. It has acceptable internal consistency and
test-retest reliability. Research suggests that the BHS may be helpful for identifying individuals
who are at risk of dying by suicide. In a sample of psychiatric outpatients, 16 of the 17 (94%) of
those who died by suicide had BHS scores of 9 or higher (Beck, Brown, Berchick, & Stewart,
1990). The BHS was collected during the baseline session, treatment session, and final session.
Beck Scale for Suicide Ideation (BSS; Beck & Steer 1993c). The BSS is a 21-item
self-report measure that has been validated as a measure of suicidal thoughts and plans over the
past week. It was used in the current study to screen out individuals with current suicidal
ideation. The items are scored on a three-point (0 - 2) Likert-type scale, although only 19 of the
items are scored, yielding total scores ranging from 0 to 38. The two un-scored items assess the
number of previous suicide attempts and the suicide intent in the last attempt. The BSS has high
internal reliability and moderate test-retest validity (Beck & Steer, 1993c). The BSS was
collected during the baseline session, treatment session, and final session.
Disturbing Dreams and Nightmare Severity Index (DDNSI, Krakow, et al. 2002). The
DDNSI is a revised version of the Nightmare Frequency Questionnaire (Krakow, et al., 2000)
and was used to measure nightmare severity and frequency. It measures the number of nights
with nightmares per week (0-7 nights) and number of total nightmares per week (0-14
nightmares). The DDNSI also measures the severity and intensity of the nightmare on a Likerttype scale ranging from no problem (0) to extremely severe problem (6) as well as how often
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nightmares result in awakenings ranging from never/rarely (0) to always (4). A score greater than
10 may indicate the presence of a nightmare disorder (Krakow, et al., 2002). The DDNSI has
shown acceptable reliability (a = 0.87) in prior studies (Nadorff, et al., 2011). The DDNSI was
collected during the baseline session, treatment session, and final session.
Insomnia Severity Index (ISI; Bastien, Vallieres, & Morin, 2001). The ISI is a 7-item
self-report scale that assesses the individual’s subjective report of insomnia for the past two
weeks. Each item is scored on a 0-4 scale, with total scores ranging from 0-28. Scores of 0-14
are considered to be sub-clinical insomnia or no insomnia, 15-21 are considered moderate
insomnia, and 22-28 are considered to be severe insomnia. The ISI has been shown to have
adequate test-retest reliability over three months and concurrent validity with sleep diaries and
polysomnography, and has been used in previous research as a measure of insomnia severity
(Bastien, Vallieres, & Morin, 2001; Savard, Savard, Simard, & Ivers, 2005). The ISI has also
been used to determine the presence or absence of clinically significant insomnia symptoms
using a cutoff of 15 (Bernert, Turvey, Conwell, & Joiner, 2007; Tang, Wright, & Salkovskis,
2007). The ISI was collected during the baseline session, treatment session, and final session.
Michigan Assessment-Screening Test for Alcohol and Drugs (MAST/AD;
Westermeyer, Yargic, & Thuras, 2004). The MAST/AD is a 24-item yes/no scale that is scored
on a weighted scale. It is a revision to the Michigan Alcohol Screening Test (MAST; Selzer,
1971) designed to screen for alcohol and drug abuse and dependence. The only modification to
the original MAST was that the term “alcohol” on the MAST was replaced with “alcohol and/or
drugs” on the MAST/AD. In the current study, it was used to help identify individuals who are
likely abusing or dependent upon drugs or alcohol. Since the only change in the measure is the
wording to include drugs in each item in addition to alcohol, a cutoff score of 13, which has been
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established for the MAST (Ross, Gavin, & Skinner, 1990), was used to identify those who may
be at risk of abusing drugs or alcohol. If above cutoff, participants were then asked questions
modeled after the DSM criteria for alcohol and substance abuse and dependence, and were
excluded if they met criteria for either alcohol or substance use or dependence. The MAST/AD
was collected during the baseline session, treatment session, and final session.
Positive and Negative Affect Scales (PANAS; Watson, Clark, & Tellegen, 1988). The
PANAS is a 20-item measure designed to measure positive and negative affect. The PANAS has
been used to assess affect in a variety of different time periods ranging from the present moment
to the last year (Watson, et al., 1988) and has been used daily in several studies to assess daily
mood (Denissen, Butalid, Penke, & van Aken, 2008; Jones, O'Connor, Conner, McMillan, &
Ferguson, 2007; Roper & Yorgason, 2009). In the current study, participants completed the
PANAS daily online.
The PANAS consists of 20 adjectives (e.g. for positive affect: inspired, attentive, and
enthusiastic; for negative affect: distressed, scared, ashamed). Each adjective is rated on a scale
from 1 (very slightly or not at all) to 5 (extremely). The PANAS has been shown to be related to
distress, depression, and state anxiety. It has been shown to have adequate internal consistency
with a Cronbach's alpha of .90 for positive affect and .87 for negative affect when assessing one's
affect for that day (Watson, et al., 1988).
PTSD Checklist-Civilian Version (PCL; Weathers, et al., 1993). The PCL is a measure
of Posttraumatic stress disorder symptom severity. It consists of 17 questions in which
participants are asked if they are bothered by each symptom on a scale ranging from 1 (not at all)
to 5 (extremely), with total scores ranging from 17 to 85 (Weathers, et al., 2003). There is no
single agreed-upon cutoff for the PCL, but 44 and 50 have each been used as cutoff scores in
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prior research (Ruggiero, Del Ben, Scotti, & Rabalais, 2003). The PCL has high internal
consistency (alpha = 0.94) and has been shown to be valid when compared to a clinicianadministered PTSD scale (Peterlin, Tietjen, Meng, Lidicker, & Bigal, 2008). The PCL has
shown acceptable reliability (a = 0.92) in prior studies (Nadorff, et al., 2011). The PCL was
collected during the baseline session, treatment session, and final session.
Clinician-Administered PTSD Scale (CAPS; Blake, Weathers, Nagy, & Kaloupek,
1995). The CAPS is a widely-used structured interview designed to help researchers diagnose
post-traumatic stress disorder using DSM-IV criteria. It is made up of 30 questions, 17
corresponding with DSM symptoms of PTSD, broken into three clusters: re-experiencing,
avoidance/numbing, and hyperarousal. Items are scored on a five-point Likert-style scale
ranging from 0 to 4. A symptom is counted as present if the frequency score is 1 or greater and
the severity is 2 or greater. By looking at the symptoms endorsed, the CAPS interview can be
used to diagnose current and lifetime PTSD according to DSM-IV criteria (Blake, et al., 1995).
The CAPS interview was administered to assess current PTSD during the baseline and final
session.
Qualitative Nightmare Questions: Open-ended questions about the experience of
having nightmares were developed for this study for the qualitative aim (see Appendix 10).
These questions asked participants to describe their nightmares, the effect nightmares have on
their lives, how their nightmares have changed over time, and their discussions about nightmares
with their healthcare providers. The qualitative questions were administered during the baseline
session.
Procedure
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Four participants were recruited from the community through a story in the campus
newspaper, advertisements on public access TV, an email notification to faculty and staff at the
host institution, and advertisements on the PRT screens. Participants who were interested in the
study and passed the initial phone screening (assessing whether the individual reported, on
average, three nightmares per week or more) attended an individual baseline session at the Quin
Curtis Center for Psychological Services at West Virginia University. During this session, the
study was explained and informed consent was obtained from the participant. The participants
then were administered the CAPS structured clinical interview, to assess for PTSD, and
completed the ISI, DDNSI, BDI, BAI, BHS, BSS, and PCL. The researcher then conducted an
unstructured clinical interview to assess the participant’s nightmares in order to determine if the
participant had, on average, at least three nightmares per week over the last six months and met
criteria for nightmare disorder based upon ICSD-2 criteria (American Academy of Sleep
Medicine, 2006). The researcher also assessed for current alcohol or drug abuse and current
suicidal ideation during the unstructured interview. Individuals not meeting criteria for
nightmare disorder, with current suicidal ideation (defined as a score > 0 on items 4-5 on the
BSS), or who were currently abusing alcohol or drugs (defined as a MAST/AD score over 12
and meeting criteria for alcohol or substance use or dependence) were excluded from the study.
The remaining participants were asked to describe their nightmares and to talk about what it is
like to have nightmares (see appendix 10 for questions). A directed content analysis was then
conducted to analyze the qualitative information. The qualitative information was videotaped
and transcribed under each question. Then, salient expressions made by each participant were
identified and synthesized.
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Following the initial session, the participants were contacted to let them know whether or
not they met the study’s inclusion criteria. The participants who met the inclusion criteria then
came back to the clinic so they could be trained on how to login to a website so they could
complete the PANAS and nightmare questions daily, as well as be given an actigraph.
Design
The study utilized a non-concurrent multiple baseline design. Similar to a concurrent
design, the treatment sessions were staggered, but participants started the study at different times.
Non-concurrent multiple baseline designs have several strengths. First, they do not require the
withdrawal of treatment, which would be impossible in IRT since IRT involves learning skills
that cannot be withdrawn. Second, the effect is replicated, strengthening the likelihood that the
effect is due to the treatment and not confounding factors. However, non-concurrent multiple
baseline designs also have limitations. First, although one can demonstrate an association with
temporal precedence between an independent and dependent variable, it is not a causal design. It
also requires that a stable baseline be established prior to treatment, which is a limitation as it
may delay the administration of treatment. Third, confounding effects, such as period effects,
may exist since the participants did not begin at the same time. Lastly, a multiple baseline
design requires frequent measurement, which may be taxing on the participant. Despite these
limitations, a multiple baseline design is a strong study design that enabled the study of IRT in a
more detailed way than had been done previously.
Baseline began for each participant as soon as they were able to come in and receive the
actigraph following the initial session. Daily nightmare frequency and severity ratings were
aggregated into weekly scores. Participants remained in baseline until a stable nightmare
frequency baseline was established (no negative trend in the last three weeks). Once the baseline
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was stable, the researcher contacted the participant to schedule the therapy session.
Occasionally, there were a few days between when the participant reached stability and when
they were able to come in for a treatment session (M = 2.25, range 0 – 5). However, the
participants’ nightmare trends were either stable or increasing over this brief period, so treatment
was still indicated.
Prior to the treatment session, the participants once again completed the ISI, DDNSI,
BDI, BAI, BHS, BSS, and PCL. No participants reported current suicidal ideation (defined as a
score > 0 on items 4-5 on the BSS), but should they have done so, they would have been referred
for depression treatment and would receive nightmare treatment at a later time. The session
began with psycho-education about nightmares. Participants were told that nightmares are “a
learned behavior” (Krakow, 2002, p. 18) and that behaviors can be un-learned. Participants also
received information about sleep hygiene as part of the psycho-education. The researcher then
discussed the causes and course of nightmares, including how nightmares are thought to be a
“learned behavior” (Krakow, 2002, p. 18). The researcher then presented the process of
changing one’s nightmares and rehearsing the new dream. Lastly, the participant and researcher
discussed how to overcome or avoid potential obstacles that may prevent the participant from
having a positive outcome.
A follow-up session was scheduled with participants one month after treatment. During
this session, a researcher administered the CAPS structured interview and asked the participant
to complete the ISI, DDNSI, BDI, BAI, BHS, and PCL. Appropriate referrals were available for
participants if required.
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Results
Participants were in the baseline condition until their last three weeks showed a positive
trend (range 3 - 8 weeks). Should a participant reach stability during the same week that another
had received treatment, the participant remained in the baseline condition until they were stable
during a week in which no one had received treatment. Thus, no two participants received
treatment during the same week. All treatment sessions were rated using a checklist to ensure
that the treatment provided was faithful to IRT. All sessions were rated as having strong fidelity,
indicating that all components of IRT were adequately covered. Participants were asked whether
they practiced their new dream every day as part of the daily online questionnaire. Overall,
participants reported practicing during 95.7% of the days following treatment, practicing on
average 1.75 times per day (SD = 0.62).
Regression coefficients for nightmare frequency assessed by the event marker were
calculated for the entire baseline, as well as the last three weeks of baseline, for every
participant. The regression coefficient for the entire baseline for participant 001 was b = 0, for
participant 008 was b = -0.09, for participant 010 was b = 0.02, and for participant 012 was b =
0.04. For the last three weeks of baseline, the regression coefficient for participant 001 was b =
0, for participant 008 was b = 0.14, for participant 010 was b = 0, and for participant 012 was b =
0.14.
The data for the study were analyzed using visual inspection for each participant.
Following the analysis of each graph, an overall conclusion was made based upon the data from
all four participants.
We first evaluated whether or not nightmares and disturbing dreams (measured together)
are reduced following IRT. The first hypothesis stated that there would be a decrease of at least
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two nightmares and disturbing dreams per week between baseline and the end of the follow-up
period after treatment with Imagery Rehearsal Therapy. First, the results for nightmare
frequency measured by the event marker will be presented, as this was the primary measure,
followed by nightmare frequency as measured by an online questionnaire (see Figure 2.
Participant 001 showed a weak treatment effect on level with no change in trend.
Participant 008 showed no treatment effect. Participant 010 demonstrated a weak treatment
effect with a possible change in level, although the reduction was less than two nightmares per
week. Lastly, participant 012 showed no clear change in trend or level. Overall, there were no
standout effects. However, there were minor initial reductions in nightmare frequency for
participants 001, 010, and 012, where the participant’s first point after treatment was lower than
the last two points of baseline. Overall, based upon nightmare frequency as measured by the
actigraph’s event marker, the first hypothesis was not supported.
The online questionnaire nightmare frequency, an alternate measure of nightmare
frequency, was also examined. For participant 001, the overall trend was negative, making it
difficult to determine whether there was an effect. However, there appears to be a weak change
in level. Participant 008 had no change in level but a change in trend. Participant 010 had no
change in level or trend, but did have a change in variability, with substantially less variability
following treatment when compared to baseline. Lastly, participant 012 showed a change in
trend, but no change in level. Overall, only one participant showed a weak change in level,
although two demonstrated a change in trend. Thus, similar to the nightmare frequency as
measured by event marker analyses, there was not a substantial change in nightmare frequency
following treatment as measured by an online questionnaire.
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Next we examined what occured immediately following nightmare treatment. Although
treatment was expected to be associated with a decrease in nightmares and disturbing dreams,
one objective of the project was to evaluate whether there is a temporary increase in nightmares
and disturbing dream frequency, severity, and negative affect in the week following treatment.
It was also postulated that there will be an increase in nightmare and disturbing dream
frequency in the week following treatment when compared with baseline (see Figure 2).
Examining the nightmare frequency data from the event marker, three of the four participants
(001, 008, and 012) had a reduction in nightmare frequency in the week following baseline when
compared to the last week of baseline, while 010 had stable nightmare frequency. When
compared to the entire baseline, participant 001 had a weak negative change in level, and the
other participants were stable. The online questionnaire nightmare frequency data paint a similar
picture, with all four participants having a decrease in nightmares during the week following
treatment when compared with the last week of baseline. When the first week post-treatment
was compared with the overall baseline, none of the participants demonstrated a change in level.
Thus, the fifth hypothesis was not supported as nightmare frequency did not increase in the first
week after treatment on either event marker or online questionnaire.
We also predicted that there would be a decrease in nightmare and disturbing dream
severity between baseline and the end of the follow-up period after treatment with IRT (see
Figure 5). Participant 001 again had a negative trend, making it difficult to show a treatment
effect, with a possible weak change in level. Participant 008 showed a weak change in trend, but
no change in level. Participant 010 showed a weak and transient change in level, as nightmare
severity decreased immediately after treatment, but then began to trend positively again. Lastly,
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participant 012 had a possible change in trend, but no change in level. Overall, hypothesis two
was not supported, as the changes on trend and level were weak and mixed.
It was also anticipated that there would be an increase in nightmare and disturbing dream
severity in the week following treatment when compared with baseline (see Figure 5).
Examining the nightmare severity data, all four participants had a reduction in nightmare severity
in the week following baseline when compared to the last week of baseline. When compared to
the entire baseline, none of the participants had a change in level. Thus, the sixth hypothesis was
not supported, as nightmare severity did not increase in the first week after treatment.
Hypothesis three stated that participants would have fewer nocturnal awakenings of 10
minutes or longer post-treatment when compared to baseline (see Figure 6). For participant 001,
there was a positive change in level, with potential change in trend. Participant 008
demonstrated an increase in variability following treatment, but no clear change in trend or level.
Participant 010 was stable with no change in level or trend. Lastly, participant 012 had a stable
trend, but a positive change in level. Overall, the third hypothesis was not supported, as none of
the participants had a reduction in nocturnal awakenings. In fact, two of the four participants
showed an increase in nocturnal awakenings. It appears that the increases are idiosyncratic, and
when they do occur, they often result in a change in level with no substantial effect on sleep
efficiency.
The fourth hypothesis postulated that participants would have higher sleep efficiency at
of the end of the follow-up period when compared to baseline (see Figure 7). For all four
participants, there was no change in level or trend, indicating a lack of an effect. Therefore, the
fourth hypothesis was not supported.
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The last hypothesis is that there would be an increase in negative affect in the week
following treatment when compared with baseline (see Figure 8). In the week following
treatment, participant 001’s negative affect was substantially higher than the last week of
baseline, and was slightly higher than the overall baseline, indicating a weak change in level.
Participant 008 had a slight decrease in negative affect in the week following treatment, with no
overall change in level when compared to the entire baseline. Participant 010 had a small
decrease in negative affect when compared to the last week of baseline, and overall a small
negative change in level. Lastly, participant 012 had a slight increase in negative affect in the
week following treatment when compared to the last week of baseline, but when compared to the
overall baseline there was no change in level. Overall, the immediate effect of treatment on
negative affect appears to be idiosyncratic. Looking first at the trend, there was an increase in
trend in half of the cases, and a decrease in the other half. The findings were also mixed in
relation to level: there was a weak increase in level in one case, weak decrease in level in one
case and no change in level in the other two. Due to the lack of consistent findings suggesting
that negative affect increases immediately following treatment, the seventh hypothesis was not
supported.
The study also had an exploratory aim to characterize the nightmares experienced by
participants through directed content analysis. For the first question, where participants were
asked to describe the nightmares they had most often, the participants reported few recurrent
dreams or dreams that were replays of actual events. Instead, the dreams were often described as
being strange, or unrealistic. Three of the four participants described having nightmares that
were based on topics they were anxious about, such as relationships or school. Question two
asked the participants to describe the effect that nightmares had on their lives. Two participants
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reported that following a nightmare it was difficult to figure out what is real and what was part of
the dream, and it took some time to get back to reality. Relatedly, a third participant reported
feeling anger at her significant other due to negative dreams about him. The fourth participant
reported that her nightmares often led her to avoid sleep, which she felt increased her depression
and anxiety symptoms. Participants were also asked to describe how they felt immediately after
having a nightmare. Half of the participants reported waking up sweating, with their heart
racing, and two reported feeling very confused about what reality is. Further, two of the
participants reported feeling tired or fatigued after having a nightmare. Thus, all participants
reported that nightmares were negative experiences.
Questions three, five and six examined how the participants’ nightmares have evolved
over time, as well as what they believe may lead to having nightmares. The participants reported
that they believed that their past experiences and current situations have significantly contributed
to the nightmares. Three of the four participants reported that prior experiences or stressful
events have contributed to their nightmare problems, and the fourth participant believed that her
current situation was the greatest contributor to her problems. The nightmares participants
experienced also seem to have changed over time in both content and intensity. For two of the
participants, they reported having nightmares that were not based on reality when they were
younger (e.g. being chased by a wolf) but now having nightmares involving people they actually
know or real events. All four participants reported more recently having nightmares involving
people they knew or actual events in their life. Intensity was idiosyncratic, with one participant
reporting a decrease in intensity over time, and one reporting an increase in intensity over the
years.

As far as the events that participants believed may make it likely that they would have a

nightmare that night, two participants reported that feeling stressed, putting things off, or having
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bad things happen during the day would trigger nightmares. However, not everyone reported
that they knew what triggered their nightmares, as the other two participants said they were
unsure what led to them have nightmares.
The last two questions asked participants what they felt was the most important aspect of
having nightmares, as well as whether or not they have reported their nightmares to health care
providers. Two of the four participants reported that the most important aspect of having
nightmares to them was wondering why they had them, and what the dreams may mean. The
other two participants focused on the way that nightmares affect them, one discussing avoiding
sleep, and the other reporting feelings of dread. Despite the negative effects of nightmares, and
the questions the participants have about having nightmares, only two of the four participants
reported having discussed nightmares with health care providers, with both of those disclosures
being to psychotherapists. It is not clear whether or not those discussions were prompted by the
participant or by the therapist.
The results from the exploratory questionnaires, as well as questionnaires utilized for
inclusion/exclusion criteria, can be found in Table 1. These data are included to characterize the
sample.
Discussion
The present study is the first to examine the effects of Imagery Rehearsal Therapy
continuously, which allows the current study to explore the mechanisms of change that had
previously been ignored by research. It was also strengthened through its use of a single-subject
design, which is ideal for examining intra-individual change over time. There was not a
substantial decrease in nightmare frequency or severity following treatment with IRT. However,
there are several potentially notable findings. First, the finding that nightmare frequency and
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severity did not increase in the week following treatment is clinically significant. Prior to this
study, clinicians were urged not to use Imagery Rehearsal Therapy with individuals who are at
risk of suicide for fear that the therapy may increase nightmare frequency and severity, leading to
an increase in suicide risk (Talbot, 2009). However, given the lack of a treatment effect, it is
possible that the treatment was inert, explaining why there was no change in nightmare
frequency and severity. Additionally, although we did not consistently find an increase in
negative affect following treatment, some participants did show an increase, suggesting that
IRT’s effect on negative affect may be idiosyncratic. Thus, more research is needed to
investigate whether IRT leads to temporary increases in nightmare frequency, severity, and
negative affect.
The current study failed to replicate prior findings that IRT leads to a substantial
reduction in nightmare frequency and severity. Although, on average, there appears to have been
a decrease in nightmare frequency and severity, the amount of variability masks any treatment
effects. Further, on secondary measures (i.e. measures that did not require stability prior to
treatment), the presence of a negative trend in some graphs made it impossible to determine
whether a change was due to treatment or the continuation of a negative trend.
There may be several possible reasons for these negative findings. This failure to
replicate may be due to the short time to follow-up when compared to other studies investigating
IRT. Most IRT studies follow participants for three months or longer post-treatment (Krakow,
Hollifield, et al., 2001; Krakow, et al., 2000; Krakow, Johnston, et al., 2001; Krakow, et al.,
1993; Krakow, et al., 1996; Krakow, Sandoval, et al., 2001), whereas the current study only
followed participants for four weeks post-treatment. The shorter follow-up period was chosen
because the present study required daily monitoring of nightmares and wearing an actigraph, and
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hence a longer follow-up period would have significantly increased participant burden. Further,
a literature review revealed no research that suggested that IRT would require more than a month
to show a clinically-significant effect. Given that research has shown that the effects of IRT
improve from three months post-treatment to six-months post-treatment (Krakow, et al., 1996), it
is very possible that the study’s follow-up was too soon to see a substantial treatment effect, as
the effect may grow over time. It is also possible that a one session treatment with no booster
sessions is not a strong enough intervention to see a substantial reduction in nightmare
frequency.
The current study significantly adds to the literature by qualitatively examining the
experience of having nightmares. This examination not only gives us a glimpse into what it is
like to have nightmares, but also has implications for how we treat nightmares. Through better
understanding the nightmare experience, researchers can design new treatments. Further, since
no two patients are alike, through better understanding the antecedents and consequences of
nightmares we can better tailor our interventions to each client. Participants reported that their
nightmares were mostly strange or unrealistic, instead of being replays of traumatic events. This
may be due to participants having idiopathic nightmares, as none of them met criteria for PTSD
based upon the CAPS interview. It was also interesting that several participants reported that
their nightmares occurred more often during times that they were anxious or stressed, and that
the content of the nightmare was often about things they were anxious or stressed about. This
finding suggests that nightmares may be associated with anxiety, which should be investigated in
future research. It also has treatment implications. Given that our participants reported that
nightmares are often tied with anxiety and/or stress, they may benefit from learning relaxation
and stress management skills.
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Looking at the negative effects of nightmares, participants reported both physical and
psychological effects. Physically, two participants reported waking up sweating with their heart
racing, and two more reported feeling fatigued after having a nightmare. Psychologically,
participants reported being confused, angry at others, and were left questioning what is real and
what was just a dream. Further, one participant reported that she avoided sleep, especially after a
nightmare, for fear of having the same dream again. The severity of the nightmare experience
was striking. One participant reported that she often had to call her significant other in another
state to calm down enough to return to sleep, and a second participant reported that she would
often avoid sleep due to fear of having a nightmare. Thus, it is easy to see how nightmares can
significantly affect one’s sleep, and hence one’s quality of life.
Although participants reported that nightmares had a significant negative effect on their
life, and they also reported having questions about the reasons for and meaning of their
nightmares, only two of the participants had mentioned having nightmares to a health care
professional, and none reported having received treatment for nightmares in the past. This
suggests that both nightmare sufferers and clinicians may be unaware that nightmares have
negative consequences, or that treatment options exist. Given the numerous negative
consequences of nightmares, and their association with various psychiatric disorders, it is
important for health care providers to identify individuals with nightmares and refer them for
proper treatment.
Limitations
Although the use of a multiple baseline design is one of this study’s greatest strengths, it
also has some limitations. First, due to requiring a stable baseline and multiple measurements,
multiple baseline designs are not ideal for treatments that take a long time to show an effect. The
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results of this study suggest that IRT may take more than a month to show an effect, and hence,
the current study was limited by its relatively short time to follow-up of four weeks. Although
this study was limited by the short follow-up, it also adds to the literature by suggesting that IRT
may take longer than four weeks to see a substantial reduction in symptoms. The current study
was also limited by an unexpectedly high degree of variability in nightmare frequency and
severity, which made it difficult to find an effect using multiple baseline design. Utilizing longer
aggregation periods, such as two weeks or a month instead of one week, would reduce the
negative effect of the variability on the design and make the design more appropriate for
studying nightmares. Lastly, the multiple baseline design employed did not allow for us to
control for the placebo effect. This could have been done by either utilizing a group design, or a
ABAC design where B is a placebo treatment and C is the treatment of interest.
However, despite being one of the weakest of the single-subject designs, the nonconcurrent baseline design has several advantages over group designs. Primarily, multiple
baseline designs are ideal for looking at change within individuals over several time points,
which is not suited to group designs. Since the goal of the study was to look at daily change
within individuals, the multiple baseline design was ideal for examining whether nightmare
frequency, severity, and negative affect increased shortly after treatment.
Although treatment adherence was rated strongly in the present study, we failed to see a
substantial reduction in nightmare frequency or severity. This may be due to participants not
understanding the treatment, even though it was presented properly. Future research should
incorporate measures of understanding to ensure that participants comprehended the treatment.
The generalizability of the study was limited by the small number of participants, as well
as the fact that all participants were female and had idiopathic nightmares. However, these
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limitations fit well with the multiple baseline design, which works best when as many potential
confounds are controlled as possible.
Conclusions and Future Directions
Although the present study failed to show a treatment effect for IRT on nightmare
frequency and severity, it adds to the literature by demonstrating that in this sample nightmare
frequency, severity, and negative affect did not increase in the week following IRT. This is
important as the treatment’s author has stated that IRT should not be used with individuals at risk
of suicide due to anecdotal evidence that treatment may increase nightmare frequency (Talbot,
2009). However, past research has shown that having nightmares significantly increases the risk
of suicide re-attempt (Sjöström, et al., 2009), and as such those at risk of suicide may greatly
benefit from nightmare treatment. Further research is needed to examine whether nightmares
increase following IRT in a larger sample, and if so, whether or not it leads to an increase in
suicidal ideation.
The use of a multiple baseline design was a significant strength of the present study, as it
made it possible to examine the participants’ responses day-by-day so one could look for
increases in nightmares or negative affect immediately following treatment. The results of this
study suggest, however, that it may not have been implemented optimally, which may explain
the lack of results. First of all, it was extremely difficult to find participants who reported
enough nightmares to see an effect with weekly aggregation. Although this could be addressed
by aggregating over two weeks, or a month, instead of one week, it would significantly increase
the length of the study. Second, it became clear that nightmares are highly variable, which
makes it difficult to establish a stable baseline and, hence, conclusions about treatment effects.
Aggregating over a longer period of time would have likely reduced the variability in the
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measures. Lastly, the present study suggests that participants may not see a significant benefit
from IRT in the first month post-treatment. In order to examine whether there was a treatment
effect, one would likely have to significantly lengthen the follow-up period, which would add to
participant burden and potentially make the study infeasible. In sum, the utilization of a multiple
baseline design was invaluable for assessing whether treatment led to a transient increase in
nightmares and negative affect. However, to be used effectively, one should aggregate over a
longer period of time, which may reduce the feasibility of using a single-subject design. Future
research may want to utilize a mixed design, where the study utilizes a multiple baseline design
which ends shortly after treatment, but the study continues to follow the participants for three to
six months post-treatment.
In conclusion, although the present study failed to replicate the findings of other studies
that nightmare frequency and severity are reduced by IRT, it does provide evidence that
nightmare frequency and severity do not increase immediately following treatment. It is hoped
that this study lay the groundwork for future studies examining whether nightmare treatment,
such as IRT, may be beneficial for individuals at risk of suicide. The current study also
significantly adds to the literature by qualitatively examining the nightmare experience, which is
an important aspect of the nightmare experience that has not been examined in previous studies.
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The Beck Anxiety Inventory was not included in the appendix due to it being copyrighted. It
may be purchased by Pearson Assessments.
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Appendix 2: Beck Depression Inventory – II
The Beck Depression Inventory - II was not included in the appendix due to it being copyrighted.
It may be purchased by Pearson Assessments.
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The Beck Hopelessness Scale was not included in the appendix due to it being copyrighted. It
may be purchased by Pearson Assessments.
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The Beck Scale for Suicide Ideation was not included in the appendix due to it being
copyrighted. It may be purchased by Pearson Assessments.
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Appendix 5: The Disturbing Dreams and Nightmares Severity Index
1. How often did you have disturbing dreams and/or nightmares: (Circle one, then follow the arrow)
Never

STOP HERE: NO OTHER QUESTIONS NEED TO BE ANSWERED

Yearly
Monthly
Weekly

How many NIGHTS in a
week did you have disturbing
dreams and/or nightmares?
1 2 3

4 5 6 7

How many NIGHTS in a
month did you have disturbing
dreams and/or nightmares?
1

How many disturbing dreams
and/or nightmares did you
have in a week?

2

How many NIGHTS in a year
did you have disturbing dreams
and/or nightmares?

3

1 2 3 4 5 6 7 8 9 10 11

How many disturbing dreams
and/or nightmares did you
have in a month?

How many disturbing dreams
and/or nightmares did you
have in a year?

GO TO QUESTION #2

STOP HERE

2. Please estimate the NUMBER of months or years you have had disturbing dreams and/or nightmares:
_____months _____years
3. On average, do your nightmares wake you up? (Circle answer)
Never/Rarely

Occasionally

Sometimes

Frequently

Always

4.How would you rate the SEVERITY of your disturbing dreams and/or nightmare problem? (Circle answer)
No
Problem

Minimal
Problem

Mild
Problem

Moderate
Problem

Severe
Problem

Very Severe
Problem

Extremely Severe
Problem

5.How would you rate the INTENSITY of your disturbing dreams and/or nightmares? (Circle answer)
Not
Intense

Minimal
Intensity

Mild
Intensity

Moderate
Intensity

Severe
Intensity

Very Severe
Intensity

Extremely Severe
Intensity
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Appendix 6: The Insomnia Severity Index
Insomnia Severity Index (T. A. Nielsen et al.)
1. Please rate the current (i.e. last 2 weeks) SEVERITY of your insomnia problem(s).

Difficulty Falling
Asleep:
Difficulty Staying
Asleep:
Problem waking too
early:

None
0

Mild
1

Moderate
2

Severe
3

0

1

2

3

0

1

2

3

2. How SATISFIED/dissatisfied are you with your current sleep pattern?
Very Satisfied
Very Dissatisfied
0
1
2
3
4
3. To what extent do you consider your sleep problem to INTERFERE with your daily
functioning (e.g. daytime fatigue, ability to function at work/daily chores, concentration,
memory, mood, etc.)
Not at all
Interfering
0

A Little

1

Somewhat

2

Much

Very Much
Interfering

3

4

4. How NOTICABLE to others do you think your sleeping problem is in terms of impairing
the quality of your life?
Not at all
A Little
Somewhat
Much
Very Much
Interfering
Interfering
0

1

2

3

4

5. How WORRIED/distressed are you about your current sleep problem?
Not at all

0

A Little

1

Somewhat

2

Much

3

Very Much

4
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Appendix 7: The Michigan Assessment Screening Test for Alcohol and Drugs (MAST/AD)

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

19
20
21

22

23

Do you enjoy a drink or drug use every now and then?
Do you feel you are a normal drinker or drug user? (By normal, we
mean you drink or use drugs less than or as much as most other people)
Have you ever awakened the morning after some drinking or drug use
and found that you could not remember a part of the evening?
Does your wife, husband, a parent, or other near relative ever worry or
complain about your drinking or drug use?
Can you stop drinking or using drugs without a struggle after one or two
drinks or drug doses?
Do you feel guilt about your drinking or drug use?
Do friends or relatives think you are a normal drinker or drug user?
Are you able to stop drinking or drug use when you want to?
Have you ever attended a meeting of Alcoholics Anonymous, Narcotics
Anonymous or other self-help group for drug use?
Have you gotten into physical fights when drinking or using drugs?
Has your drinking or drug use ever created problems between you and
your wife, husband, a parent, or other relative?
Has your wife, husband (or other family members) ever gone to any one
for help about your drinking or drug use?
Have you ever lost friends because of your drinking or drug use?
Have you ever gotten into trouble at work because of your drinking or
drug use?
Have you ever lost a job because of drinking or drug use?
Have you ever neglected your obligations, your family, or your work for
two or more days in a row because you were drinking or using drugs?
Do you drink or use drugs before noon fairly often
Have you ever been told you have liver trouble? Cirrhosis?
After heavy drinking or drug use have you ever had Delirium Tremens
(D.T.’s) or severe shaking, or heard voices, seen things that weren’t
really there? How many times?
Have you ever gone to anyone for help about your drinking or drug use?
Have you ever been in the hospital because of drinking or drug use?
Have you ever been a patient in a psychiatric hospital or on a psychiatric
ward of a general hospital where drinking or drug use was a part of the
problem that resulted in your hospitalization?
Have you ever been seen at a psychiatric or mental health clinic or gone
to any doctor, social worker, or clergyman for help because of any
emotional problem, where drinking or drug use was part of the
problem?
Have you ever been arrested for drunk driving, driving while
intoxicated, or driving under the influence of alcoholic beverages or
drugs? How many times?

Yes

No

0
0

0
2

2

0

0

1

0

2

1
0
0
5

0
2
2
0

1
2

0
0

2

0

2
2

0
0

2
2

0
0

1
2
2

0
0
0

5
5
2

0
0
0

2

0

2

0
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Have you ever been arrested, or taken into custody, even for a few
hours, because of other drunk or drug-related behavior? How many
times?

2

71
0
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Appendix 8: The Positive and Negative Affect Schedule
This scale consists of a number of words that describe different feelings and emotions. Read
each item and then mark the appropriate answer in the space next to that word. Indicate to what
extent you have felt this way today. Use the following scale to record your answers.
1
Very slightly or
not at all

2
A little

3
Moderately

4
Quite a bit

interested

irritable

distressed

alert

excited

ashamed

upset

inspired

strong

nervous

guilty

determined

scared

attentive

hostile

jittery

enthusiastic

active

proud

afraid

5
Extremely
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Appendix 9: The PTSD Checklist Civilian Version

INSTRUCTIONS TO PARTICIPANT: Below is a list of problems and complaints that people
sometimes have in response to stressful experiences. Please read each one carefully, select the
best option to indicate how much you have been bothered by that problem in the past month.
1.

Repeated, disturbing memories, thoughts, or images of a stressful experience?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely

2.

Repeated, disturbing dreams of a stressful experience?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely

3.

Suddenly acting or feeling as if a stressful experience were happening again (as if you were
reliving it)?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely

4. Feeling very upset when something reminded you of a stressful experience?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
5. Having physical reactions (e.g., heart pounding, trouble breathing, sweating) when
something reminded you of a stressful experience?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
6. Avoiding thinking about or talking about a stressful experience or avoiding having feelings
related to it?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
7. Avoiding activities or situations because they reminded you of a stressful experience?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
8.

Trouble remembering important parts of a stressful experience?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely

9. Loss of interest in activities that you used to enjoy?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
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10. Feeling distant or cut off from other people?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
11. Feeling emotionally numb or being unable to have loving feelings for those close to you?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
12. Feeling as if your future will somehow be cut short?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
13. Trouble falling or staying asleep?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
14. Feeling irritable or having angry outbursts?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
15. Having difficulty concentrating?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
16. Being "super-alert" or watchful or on guard?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
17. Feeling jumpy or easily startled?
1. Not at all 2. A little bit 3. Moderately 4. Quite a bit 5. Extremely
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Appendix 10: Qualitative Questions
1. Please describe the nightmares you have most often.
2. Describe for me the effect that nightmares have had on your life.
3. Describe for me the things that might make you think you will have a nightmare.
4. Tell me about how you feel after having a nightmare. Can you describe for me how you feel
physically? Psychologically? Emotionally?
5. Describe for me how your nightmares have changed over time.
6. Tell me about what you think may have contributed to your nightmares
7. Tell me about your discussions with health care providers about your nightmares?
8. When you think about your experience with nightmares, tell me about what seems most
important to you.
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Appendix 11: The Clinician Administered PTSD Scale
The Clinician Administered PTSD Scale was not included in the appendix due to it being
copyrighted. It may be purchased from Western Psychological Services.
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Appendix 12: Suicide/Homicide Threat Procedures
Participants will only be interviewed when a licensed psychologist is in the building and
has agreed to be on-call for the project. In the unusual case that an individual might report
current suicidal ideation at any point during the study, the experimenter will assess suicide risk.
The experimenter will then remain with the participant and contact the psychologist who agreed
to be on-call. Should he or she be unavailable, the experimenter will contact Dr. Fremouw, the
clinic director. The experimenter will then consult with the psychologist who agreed to be oncall. Participants who have suicidal ideation but are not deemed to be at imminent risk of suicide
will be given referrals to local mental health service providers for treatment. If a participant is at
imminent risk of suicide, the experimenter and/or the consulting psychologist will call the Valley
Health Care 24—hour crisis line, the Chestnut Ridge 24—hour help line, or Ruby Memorial
Hospital to inform them of the situation and to develop a plan of action with the contacted
agency. If the participant leaves against advice and it is determined that the participant is an
imminent threat to himself/herself, or someone else, then the Sherriff´s Department will be called
to report the situation and develop a plan of action with the assistance of the representative
contacted at the Sherriff´s office. In the event that there is no answer at the Sherriff´s
Department, the experimenter or the consulting psychologist will call 911.
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Table 1: Exploratory Self-Report Measures

001

008

010

012

Base Treat Post Base Treat Post Base Treat Post Base Treat Post
DDNSI

16

16

11.5 20

20

9.5

20

12

6

21

15

8.5

ISI

13

7

2

14

8

8

14

10

9

9

8

6

BSS

4

3

3

2

1

0

0

0

0

0

0

0

BDI

22

13

7

12

15

10

2

3

3

11

17

8

BAI

26

16

8

7

12

4

4

0

0

0

10

2

BHS

1

2

1

2

1

1

2

1

3

1

1

0

PCL

43

43

25

48

47

30

31

22

21

31

39

25

MAST/AD 15

9

8

3

3

3

3

1

1

1

1

1

CAPS

N/A

20

31

N/A

12

3

N/A

4

32

N/A

18

36

Note.*Base = start of baseline, Treat = day of treatment, Post is four week follow-up. The
DDNSI = Disturbing Dreams and Nightmares Severity Index, the ISI = Insomnia Severity Index,
the BSS = Beck Scale for Suicide Ideation, the BDI = Beck Depression Inventory-II, the BAI =
Beck Anxiety Inventory, the BHS = Beck Hopelessness Scale, The PCL = PTSD Checklist –
Civilian Version, the MAST/AD = Michigan Assessment Screening Test for Alcohol and Drugs,
the CAPS = Clinician-Administered PTSD Scale.
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Figure 1: Consort Diagram

Total Potential Participants
42

Excluded by Pre-Screening
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2

28
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12
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6

Met Inclusion Criteria
6

Dropped Out Prior To Study
Start
2

Total Participants
4
*Most common reasons for being excluded were having
Low levels of suicidal ideation and not meeting criteria for nightmare disorder
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Figure 2: Nightmare Frequency Measured By Event Marker and Online Questionnaire
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Figure 3: Average Nightmare Frequency (Event Marker)
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Figure 4: Average Nightmare Frequency (Online Questionnaire)
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Figure 5: Average Nightmare Severity
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Figure 6: Average Nocturnal Awakenings
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Figure 7: Average Sleep Efficiency
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Figure 8: Average Negative Affect
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